Viragen Inc. has received $1 million from Cytoferon Corp., aprivate company formed to invest in Viragen of Hialeah, Fla.

Cytoferon now owns about 34 percent of the company, whichplans to use the money to improve its manufacturing andlaboratory and reinitiate production of its human leukocyte(alpha) interferon product, Alpha Leukoferon.

The company is finalizing a management and marketingagreement with Cytoferon and hopes to market its interferon inthe near future. Viragen also wants to obtain joint venture andlicensing agreements.

(c) 1997 American Health Consultants. All rights reserved.